HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Huang Selected Research

Fulvestrant (Faslodex)

1/2022Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study.
2/2021Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
1/2021Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3.
1/2021Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer.
3/2019Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.
2/2019Palbociclib and Fulvestrant in Breast Cancer. Reply.
11/2018Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.
11/2018Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3.
11/2018The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial.
1/2018Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin Huang Research Topics

Disease

340Neoplasms (Cancer)
05/2024 - 03/2002
69Breast Neoplasms (Breast Cancer)
01/2024 - 01/2005
52Inflammation (Inflammations)
05/2024 - 08/2008
48Infections
05/2024 - 12/2010
45Hypoxia (Hypoxemia)
04/2024 - 01/2007
41Neoplasm Metastasis (Metastasis)
12/2023 - 06/2003
27Hepatocellular Carcinoma (Hepatoma)
03/2024 - 03/2002
26Fibrosis (Cirrhosis)
04/2024 - 08/2000
25Osteosarcoma (Osteogenic Sarcoma)
03/2024 - 03/2005
23Myasthenia Gravis
04/2024 - 08/2008
22Leukemia
04/2024 - 03/2008
21Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 04/2016
20Carcinogenesis
01/2022 - 10/2006
19Myocardial Infarction
01/2024 - 12/2016
19Body Weight (Weight, Body)
08/2022 - 11/2007
18Insulin Resistance
05/2024 - 05/2016
18Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 08/2007
18Ovarian Neoplasms (Ovarian Cancer)
10/2023 - 03/2013
18Carcinoma (Carcinomatosis)
01/2023 - 07/2005
16Hemorrhage
05/2024 - 08/2010
16Lung Neoplasms (Lung Cancer)
01/2024 - 12/2011
16Pain (Aches)
12/2023 - 12/2007
15Sepsis (Septicemia)
01/2024 - 03/2007
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 09/2010
14Thrombosis (Thrombus)
04/2024 - 01/2017
14COVID-19
04/2024 - 01/2020
14Heart Failure
02/2024 - 06/2007
14Hypertension (High Blood Pressure)
02/2024 - 08/2009
14Stomach Neoplasms (Stomach Cancer)
03/2023 - 05/2005
13Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2024 - 05/2003
13Pancreatic Neoplasms (Pancreatic Cancer)
10/2023 - 02/2009
13Renal Cell Carcinoma (Grawitz Tumor)
04/2023 - 02/2005
12Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2024 - 11/2010
12Disease Progression
03/2024 - 06/2012
12Type 2 Diabetes Mellitus (MODY)
03/2024 - 01/2012
12Obesity
01/2024 - 08/2004
12Cognitive Dysfunction
11/2023 - 01/2017
12Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 07/2015
12Necrosis
07/2023 - 07/2010
12Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2021 - 11/2010
11Virus Diseases (Viral Diseases)
11/2022 - 01/2009
10Endometriosis
12/2023 - 03/2013
10Periodontitis
10/2023 - 10/2016
9Wounds and Injuries (Trauma)
03/2024 - 08/2012
9Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2024 - 05/2015
9Lymphoma (Lymphomas)
11/2023 - 04/2004
9Lymphatic Metastasis
01/2020 - 04/2009
8Liver Diseases (Liver Disease)
04/2024 - 12/2018

Drug/Important Bio-Agent (IBA)

105Proteins (Proteins, Gene)FDA Link
04/2024 - 03/2005
79Biomarkers (Surrogate Marker)IBA
04/2024 - 09/2005
38MicroRNAs (MicroRNA)IBA
04/2024 - 04/2010
37Messenger RNA (mRNA)IBA
12/2023 - 04/2002
28CytokinesIBA
05/2024 - 03/2008
25palbociclibIBA
01/2024 - 01/2015
25Glucose (Dextrose)FDA LinkGeneric
12/2023 - 11/2010
25Hormones (Hormone)IBA
12/2023 - 01/2012
24RNA (Ribonucleic Acid)IBA
05/2024 - 12/2014
23Sunitinib (Sutent)FDA Link
04/2023 - 10/2007
22PlatinumIBA
05/2024 - 01/2018
20Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 07/2005
19Long Noncoding RNAIBA
04/2024 - 05/2015
19Therapeutic UsesIBA
11/2023 - 07/2003
17LipidsIBA
12/2023 - 01/2011
17Cisplatin (Platino)FDA LinkGeneric
12/2023 - 02/2011
17Circular RNAIBA
12/2023 - 01/2019
16DNA (Deoxyribonucleic Acid)IBA
05/2024 - 05/2003
16EnzymesIBA
02/2024 - 05/2004
15Interleukin-6 (Interleukin 6)IBA
01/2024 - 05/2003
14CateninsIBA
04/2024 - 06/2013
14triptolideIBA
12/2023 - 01/2008
14LigandsIBA
12/2023 - 08/2007
14ErbB Receptors (EGF Receptor)IBA
12/2022 - 05/2007
13Transcription Factors (Transcription Factor)IBA
11/2023 - 12/2012
13Oxygen (Dioxygen)IBA
07/2023 - 01/2007
13Small Interfering RNA (siRNA)IBA
01/2023 - 02/2009
13salicylhydroxamic acid (SHAM)IBA
08/2022 - 10/2005
12Retinaldehyde (Retinal)IBA
01/2024 - 09/2006
12LipopolysaccharidesIBA
12/2023 - 10/2014
11Peptides (Polypeptides)IBA
03/2024 - 01/2016
10Immune Checkpoint InhibitorsIBA
05/2024 - 09/2015
10Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 03/2016
10Caspase 3 (Caspase-3)IBA
11/2023 - 11/2005
10AntigensIBA
01/2023 - 02/2005
10Fulvestrant (Faslodex)FDA Link
01/2022 - 01/2018
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2024 - 05/2003
9Indicators and Reagents (Reagents)IBA
10/2023 - 05/2013
9Tyrosine Kinase InhibitorsIBA
09/2022 - 09/2009
9Estrogen ReceptorsIBA
01/2022 - 06/2007
8InterferonsIBA
05/2024 - 01/2014

Therapy/Procedure

185Therapeutics
05/2024 - 07/2003
70Drug Therapy (Chemotherapy)
05/2024 - 10/2007
28Radiotherapy
05/2024 - 04/2012
18Immunotherapy
04/2024 - 02/2005
14Percutaneous Coronary Intervention
01/2024 - 09/2016
13Ligation
10/2023 - 01/2012
11Lasers (Laser)
08/2023 - 01/2013
10Neoadjuvant Therapy
02/2023 - 02/2011
9Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2023 - 01/2014
9Length of Stay
01/2023 - 12/2007
8Precision Medicine
04/2024 - 01/2017